VNRX
Volitionrx Ltd
NYSE MKT: VNRX · HEALTHCARE · MEDICAL DEVICES
$2.62
-0.76% today
Updated 2026-04-30
Market cap
$20.92M
P/E ratio
—
P/S ratio
12.11x
EPS (TTM)
$-4.40
Dividend yield
—
52W range
$2 – $19
Volume
13.3M
Volitionrx Ltd (VNRX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $54968.00 | $0.00 | $14785.00 | $0.00 | $0.00 | $0.00 | $0.00 | $17096.00 | $13433.00 | $90035.00 | $306392.00 | $775302.00 | $1.23M | $1.73M |
| Revenue growth (YoY) | — | — | — | — | — | — | — | -100.0% | — | -100.0% | — | — | — | — | -21.4% | +570.3% | +240.3% | +153.0% | +59.1% | +40.0% |
| Cost of revenue | — | $4000.00 | — | — | — | — | $4.00M | $0.00 | $5.81M | $0.00 | $309406.00 | $542484.00 | $639916.00 | — | — | — | $1.19M | $1.41M | $1.30M | — |
| Gross profit | — | $-4000.00 | — | — | — | — | $54968.00 | $0.00 | $14785.00 | $0.00 | $-309406.00 | $-542484.00 | $-639916.00 | $17096.00 | $13433.00 | $90035.00 | $306392.00 | $775302.00 | $1.23M | $1.73M |
| Gross margin | — | — | — | — | — | — | 100.0% | — | 100.0% | — | — | — | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | — | — | — | — | — | $1.51M | $2.84M | $2.50M | $4.04M | $6.10M | $6.84M | $8.91M | $10.91M | $10.36M | $14.53M | $13.02M | $15.33M | $19.55M | $14.41M | $10.08M |
| SG&A | — | — | — | — | $10947.00 | $1.10M | $1.30M | $1.72M | $1.91M | $3.90M | $5.43M | $5.36M | $5.78M | $4.52M | $5.47M | $14.08M | $15.35M | $15.91M | $12.72M | $9.46M |
| Operating income | $-36987.00 | $-26295.00 | $-21803.00 | $-15816.00 | $-10947.00 | $-2.61M | $-4.08M | $-4.58M | $-5.94M | $-10.01M | $-12.27M | $-15.05M | $-17.90M | $-16.04M | $-21.25M | $-28.33M | $-31.78M | $-35.99M | $-27.02M | $-21.22M |
| Operating margin | — | — | — | — | — | — | -7428.0% | — | -40158.4% | — | — | — | — | -93840.2% | -158176.2% | -31469.0% | -10372.4% | -4641.8% | -2190.9% | -1228.6% |
| EBITDA | $-36987.00 | $-26295.00 | $-21803.00 | $-15816.00 | $-10947.00 | $-13023.00 | $-3.95M | $-3.56M | $-8.07M | $-9.96M | $-11.60M | $-14.15M | $-17.26M | $-15.07M | $-19.23M | $-25.69M | $-29.24M | $-34.04M | $-25.58M | $-19.80M |
| EBITDA margin | — | — | — | — | — | — | -7181.1% | — | -54591.8% | — | — | — | — | -88149.7% | -143140.9% | -28532.0% | -9541.8% | -4390.8% | -2073.6% | -1146.1% |
| EBIT | $-36987.00 | $-26295.00 | $-21803.00 | $-15816.00 | $-10947.00 | $-131640.00 | $-4.08M | $-3.71M | $-8.21M | $-10.20M | $-11.91M | $-14.70M | $-17.90M | $-15.97M | $-20.27M | $-26.83M | $-30.43M | $-35.46M | $-26.92M | $-21.01M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $663805.00 | $0.00 | $73133.00 | $110924.00 | $126572.00 | $129799.00 | $155803.00 | $173087.00 | $221622.00 | $340362.00 | $2.49M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-36987.00 | $-26295.00 | $-21803.00 | $-15816.00 | $-10947.00 | $-2.61M | $-4.08M | $-3.71M | $-8.21M | $-9.53M | $-11.91M | $-14.77M | $-18.01M | $-16.10M | $-20.35M | $-26.81M | $-30.27M | $-35.32M | $-26.97M | $-23.36M |
| Net income growth (YoY) | — | +28.9% | +17.1% | +27.5% | +30.8% | -23728.1% | -56.5% | +9.1% | -121.4% | -16.0% | -24.9% | -24.1% | -21.9% | +10.6% | -26.4% | -31.8% | -12.9% | -16.7% | +23.6% | +13.4% |
| Profit margin | — | — | — | — | — | — | -7428.0% | — | -55553.1% | — | — | — | — | -94168.5% | -151508.3% | -29782.5% | -9879.1% | -4555.5% | -2186.3% | -1352.2% |